Pharmacokinetics of prostaglandins

被引:75
作者
Bygdeman, M [1 ]
机构
[1] Karolinska Hosp, Dept Woman & Child Hlth, Div Obstet & Gynecol, S-17176 Stockholm, Sweden
关键词
prostaglandin; prostaglandin analogues; metabolism; plasma levels;
D O I
10.1016/S1521-6934(03)00043-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Naturally occurring prostaglandins (PGs) are rapidly metabolized in the human circulation. For clinical use a number of PG analogues have therefore been developed which are resistant to rapid inactivation. Among these are carboprost, gemeprost and misoprostol. Following intramuscular injection of carboprost, plasma levels peaked after 20 minutes and declined slowly thereafter. In amniotic fluid the half-life was between 31 and 37 hours. Gemeprost is administered vaginally, and maximum plasma levels were reached after 2-3 hours, with detectable levels for at least 68 hours. Pharmacokinetic data on misoprostol are available following oral, vaginal and sublingual administration. Following oral treatment, plasma levels peaked at about 30 minutes, while after vaginal administration of the tablets the levels increased gradually and reached maximum levels after 70-80 minutes, but remained detectable for a significantly longer time. After sublingual administration the peak concentration was the same as for oral treatment but declined significantly more slowly. Endocervical administration of PGE(2) might be regarded as a local therapy, while following vaginal administration increased plasma levels of metabolites can generally be found. The plasma profile varies with the vehicle used.
引用
收藏
页码:707 / +
页数:11
相关论文
共 24 条
[1]   15-KETO-13,14-DIHYDROPROSTAGLANDIN-E2-METABOLITE AND F2-ALPHA METABOLITE LEVELS IN BLOOD FROM MEN AND WOMEN GIVEN PROSTAGLANDIN-E2 ORALLY [J].
BREMME, K ;
ENEROTH, P ;
GOTTLIEB, C ;
KINDAHL, H ;
SVANBORG, K ;
NILSSON, B ;
OLSSON, M ;
BYGDEMAN, M .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 37 (03) :169-176
[2]  
BREMME K, 1980, ACTA OBSTET GYN SCAN, P5
[3]   DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PROSTAGLANDIN-E2 METABOLITE LEVELS IN PLASMA [J].
DEMERS, LM ;
BRENNECKE, SP ;
MOUNTFORD, LA ;
BRUNT, JD ;
TURNBULL, AC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (01) :101-106
[4]   GAS-CHROMATOGRAPHIC - MASS-SPECTROMETRIC QUANTITATION OF 16,16-DIMETHYL-TRANS-DELTA-2-PGE1 [J].
DIMOV, V ;
GREEN, K ;
BYGDEMAN, M ;
KONISHI, Y ;
IMAKI, K ;
HAYASHI, M .
PROSTAGLANDINS, 1983, 25 (02) :225-235
[5]  
DIMOV V, 1986, DRUG METAB DISPOS, V14, P494
[6]  
GEMZELLDANIELSS.K, 1999, OBSTET GYNECOL, V93, P275
[7]   RADIOIMMUNOASSAY OF 15-KETO-PROSTAGLANDIN-E2 IN PERIPHERAL PLASMA AFTER ORAL-ADMINISTRATION OF PROSTAGLANDIN-E2 TABLETS USED FOR INDUCTION OF LABOR [J].
GORDON, D ;
MYATT, L ;
GORDONWRIGHT, A ;
HANSON, J ;
ELDER, MG .
PROSTAGLANDINS, 1977, 13 (03) :399-408
[8]   SYSTEMIC ABSORPTION FROM THE VAGINA OF PROSTAGLANDIN-E2 ADMINISTERED FOR THE INDUCTION OF LABOR [J].
GORDONWRIGHT, AP ;
ELDER, MG .
PROSTAGLANDINS, 1979, 18 (01) :153-160
[9]  
GRANSTROM E, 1982, METHOD ENZYMOL, V86, P306
[10]   CHEMICAL-INSTABILITY OF 15-KETO-13,14-DIHYDRO-PGE2 - THE REASON FOR LOW ASSAY RELIABILITY [J].
GRANSTROM, E ;
HAMBERG, M ;
HANSSON, G ;
KINDAHL, H .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1980, 19 (06) :933-957